These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20184501)
1. Dual contrast magnetic resonance imaging tracking of iron-labeled cells in vivo. Wu S; Zhang L; Zhong J; Zhang Z Cytotherapy; 2010 Nov; 12(7):859-69. PubMed ID: 20184501 [TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast. Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956 [TBL] [Abstract][Full Text] [Related]
3. Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies. Danhier P; Deumer G; Joudiou N; Bouzin C; Levêque P; Haufroid V; Jordan BF; Feron O; Sonveaux P; Gallez B Oncotarget; 2017 Jun; 8(24):38876-38885. PubMed ID: 28467814 [TBL] [Abstract][Full Text] [Related]
4. In vivo quantification of SPIO nanoparticles for cell labeling based on MR phase gradient images. Wang L; Potter WM; Zhao Q Contrast Media Mol Imaging; 2015; 10(1):43-50. PubMed ID: 24764174 [TBL] [Abstract][Full Text] [Related]
5. Labeling of cancer cells with magnetic nanoparticles for magnetic resonance imaging. Weis C; Blank F; West A; Black G; Woodward RC; Carroll MR; Mainka A; Kartmann R; Brandl A; Bruns H; Hallam E; Shaw J; Murphy J; Teoh WY; Aifantis KE; Amal R; House M; Pierre TS; Fabry B Magn Reson Med; 2014 May; 71(5):1896-905. PubMed ID: 23813415 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Tracking of Human Neural Progenitor Cells in the Rat Brain Using Magnetic Resonance Imaging Is Not Enhanced by Ferritin Expression. Bernau K; Lewis CM; Petelinsek AM; Reagan MS; Niles DJ; Mattis VB; Meyerand ME; Suzuki M; Svendsen CN Cell Transplant; 2016; 25(3):575-92. PubMed ID: 26160767 [TBL] [Abstract][Full Text] [Related]
7. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging. Medarova Z; Balcioglu M; Yigit MV Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923 [TBL] [Abstract][Full Text] [Related]
8. Flow-mediated stem cell labeling with superparamagnetic iron oxide nanoparticle clusters. Clay N; Baek K; Shkumatov A; Lai MH; Smith CE; Rich M; Kong H ACS Appl Mater Interfaces; 2013 Oct; 5(20):10266-73. PubMed ID: 24033276 [TBL] [Abstract][Full Text] [Related]
9. Engineered core-shell magnetic nanoparticle for MR dual-modal tracking and safe magnetic manipulation of ependymal cells in live rodents. Peng YK; Lui CNP; Chen YW; Chou SW; Chou PT; Yung KKL; Tsang SCE Nanotechnology; 2018 Jan; 29(1):015102. PubMed ID: 29205171 [TBL] [Abstract][Full Text] [Related]
10. Dual-contrast cellular magnetic resonance imaging. Dharmakumar R; Zhang Z; Koktzoglou I; Tsaftaris SA; Li D Mol Imaging; 2009; 8(5):254-63. PubMed ID: 19796603 [TBL] [Abstract][Full Text] [Related]
11. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063 [TBL] [Abstract][Full Text] [Related]
12. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis. Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592 [TBL] [Abstract][Full Text] [Related]
13. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging. Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671 [TBL] [Abstract][Full Text] [Related]
14. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging. Shanavas A; Sasidharan S; Bahadur D; Srivastava R J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648 [TBL] [Abstract][Full Text] [Related]
15. Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents. Bouziotis P; Psimadas D; Tsotakos T; Stamopoulos D; Tsoukalas C Curr Top Med Chem; 2012; 12(23):2694-702. PubMed ID: 23339765 [TBL] [Abstract][Full Text] [Related]
16. Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors. Richard S; Boucher M; Lalatonne Y; Mériaux S; Motte L Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1515-1520. PubMed ID: 28017683 [TBL] [Abstract][Full Text] [Related]
17. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs. Lee JH; Jung MJ; Hwang YH; Lee YJ; Lee S; Lee DY; Shin H Biomaterials; 2012 Jun; 33(19):4861-71. PubMed ID: 22475532 [TBL] [Abstract][Full Text] [Related]
18. Characterization of Magneto-Endosymbionts as MRI Cell Labeling and Tracking Agents. Brewer KD; Spitler R; Lee KR; Chan AC; Barrozo JC; Wakeel A; Foote CS; Machtaler S; Rioux J; Willmann JK; Chakraborty P; Rice BW; Contag CH; Bell CB; Rutt BK Mol Imaging Biol; 2018 Feb; 20(1):65-73. PubMed ID: 28616842 [TBL] [Abstract][Full Text] [Related]
19. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles. Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519 [TBL] [Abstract][Full Text] [Related]
20. Whole body MRI and fluorescent microscopy for detection of stem cells labeled with superparamagnetic iron oxide (SPIO) nanoparticles and DiI following intramuscular and systemic delivery. Odintsov B; Chun JL; Berry SE Methods Mol Biol; 2013; 1052():177-93. PubMed ID: 23733536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]